This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The company is targeting Gen Z by playing up trends in health and sustainability...
Energy Environ. Sci., 2025, Accepted ManuscriptDOI: 10.1039/D5EE01081K, Paper Op...
The European Commission unveiled a $565 million package to retain and attract sc...
Tesla owners and investors once believed the company and CEO Elon Musk were chan...
The partnership includes exclusive treatments utilizing the beauty group’s Re-Nu...
Each weekday, we select a short list of news articles and commentary related to ...
The agency is seeking comments on a newly pruned framework, which is updated to ...
Natural gas-fired generation accounts for 69% of selected Reliability Resource I...
The president proposed making deep cuts to Infrastructure Investment and Jobs Ac...
Michael Kofman and Dara Massicot join Ryan to unpack how the Trump administratio...
Modern mechanical innovations tend to make things better or worse regarding auto...
I’m writing this from a quiet table at Fowlscombe Farm in the English countrysid...
Agency will make researchers outside United States seek grants of their own rath...
Red Lobster is delighting its customers with a new margarita deal for one day only.
Lowe’s store associates have a new artificial intelligence tool designed to enh...
3G Capital will acquire Skechers for $8.2 billion in a deal set to close in Q3 2...
This is the online version of STAT’s weekly email newsletter Health Care Inc.
Human medicines European public assessment report (EPAR): Spikevax (previously C...
Human medicines European public assessment report (EPAR): HyQvia, human normal i...
Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluti...
The firm, a prolific backer of drug startups, will use the cash to back companie...
Learn how to modernize a historic home without losing its charm. Experts share ...
Jennmar's latest acquisition expands its reach in the heavy equipment maintenanc...
BioNTech is making plans to debut on the commercial oncology scene. Part of that...